PFBT
AGIO icon

Parkside Financial Bank & Trust’s Agios Pharmaceuticals AGIO Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$817 Sell
22
-40
-65% -$1.21K ﹤0.01% 2471
2026
Q1 		$2.1K Buy
62
+47
+313% +$1.33K ﹤0.01% 2101
2025
Q4 		$409 Sell
15
-30
-67% -$1.05K ﹤0.01% 2593
2025
Q3 		$1.81K Hold
45
– – ﹤0.01% 2061
2025
Q2 		$1.49K Buy
45
+15
+50% +$455 ﹤0.01% 2098
2025
Q1 		$879 Buy
+30
New +$995 ﹤0.01% 2157
2018
Q3 		– Sell
-3
Closed – – 1517
2018
Q2 		$0 Buy
+3
New +$262 ﹤0.01% 1521

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Parkside Financial Bank & Trust's AGIO Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its Agios Pharmaceuticals (AGIO) stake by 65% in Q2 2026, selling an estimated $1.21K and leaving 22 shares worth $817. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

Parkside Financial Bank & Trust first reported a position in AGIO in Q2 2018 and has held it in 7 quarters since. The position peaked at $2.1K in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Parkside Financial Bank & Trust held 22 shares of Agios Pharmaceuticals worth $817 as of Q2 2026.
  • Parkside Financial Bank & Trust sold 40 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.21K.
  • Agios Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2471 holding.
  • Parkside Financial Bank & Trust first reported a position in Agios Pharmaceuticals in Q2 2018 and has held it in 7 quarters since.
  • Parkside Financial Bank & Trust's Agios Pharmaceuticals position peaked at $2.1K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.